SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avadel AVDL -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (54)7/18/2003 8:33:02 AM
From: Arthur Radley  Respond to of 240
 
FLML will be presenting at this conference this weekend:

30th Annual Meeting & Exposition of the Controlled Release Society (Glasgow, Scotland, 19-23 July, 2003)

4 abstracts submitted:

Medusa®: a versatile nano carrier for protein delivery

Sustained release of IL-2 from Medusa® comb-like hydrophobically modified polyglutamate

Sustained release of Interferon alpha 2b from Medusa® nanoparticles of comb-like hydrophobically modified polyglutamate

Basulin®: a long acting insulin dosage form based on Medusa®



To: Brander who wrote (54)7/23/2003 4:05:41 PM
From: Arthur Radley  Read Replies (2) | Respond to of 240
 
You have to love the action today....broke through $20.00 like hot butter...looks like $21 is resistance level...

Off to NYC for a week...so keep the positive action going.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News